Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations-Reference-Cited by-同舟云学术

Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations

Published:2010-07-28 Issue:12 Volume:66 Page:1199-1205
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Pedersen Rasmus S.,Brasch-Andersen Charlotte,Sim Sarah C.,Bergmann Troels K.,Halling Jónrit,Petersen Maria S.,Weihe Pál,Edvardsen Hege,Kristensen Vessela N.,Brøsen Kim,Ingelman-Sundberg Magnus

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-010-0864-8.pdf

Reference38 articles.

1. Ingelman-Sundberg M (2004) Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 369:89–104

2. Niwa T, Murayama N, Yamazaki H (2009) Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome P450. Curr Drug Metab 10:700–712

3. Goldstein JA, de Morais SM (1994) Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4:285–299

4. Goldstein JA (2001) Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol 52:349–355

5. Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C (2007) Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116:496–526

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphisms of CYP2C19 in ecuadorian population: An interethnic approach;Heliyon;2024-04

2. Precision medicine in cardiovascular therapeutics: Evaluating the role of pharmacogenetic analysis prior to drug treatment;Journal of Internal Medicine;2024-02-11

3. Genogeografiya farmakogeneticheski znachimyh DNK-markerov CYP2C19 supersemejstva citohromov v narodonaselenii Rossii i sopredel'nyh stran;Вестник Российского государственного медицинского университета;2023-10

4. Gene geography of pharmacogenetically significant CYP2C19 cytochrome superfamily DNA markers in the populations of Russia and neighboring countries;Bulletin of Russian State Medical University;2023-10

5. Prevalence of CYP2C9 and CYP2C19 variants and the impact on clopidogrel efficacy in patients having CYPC19*2 variant;Indian Journal of Pharmacology;2023-01